Company Description

Melinta, formerly Cempra & Rib-X Pharma, is dedicated to providing innovative therapies to people impacted by acute and life-threatening illnesses. It currently markets four antibiotics: Baxdela (delafloxacin), Vabomere (meropenem and vaborbactam), Orbactiv (oritavancin), and Minocin (minocycline) for Injection.